Gwenn Hansen
CIK: 0001817160
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Nurix Therapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (58 total)
- Nov 2, 2026NRIX
Nurix Therapeutics, Inc.
Sale(S)Direct1.5K shares at avg. $26.80$39K - Nov 2, 2026NRIX
Nurix Therapeutics, Inc.
Exercise(M)Direct1.5K shares at avg. $1.86$3K - Oct 30, 2026NRIX
Nurix Therapeutics, Inc.
Exercise(M)Direct3.6K shares- - Oct 30, 2026NRIX
Nurix Therapeutics, Inc.
Sale(S)Direct4K shares at avg. $26.28$104K - Oct 30, 2026NRIX
Nurix Therapeutics, Inc.
Exercise(M)Direct3.8K shares- - Oct 30, 2026NRIX
Nurix Therapeutics, Inc.
Exercise(M)Direct2.9K shares- - Oct 15, 2026NRIX
Nurix Therapeutics, Inc.
Sale(S)Direct1.5K shares at avg. $25.00$36K - Oct 15, 2026NRIX
Nurix Therapeutics, Inc.
Exercise(M)Direct1.5K shares at avg. $1.86$3K - Sep 1, 2026NRIX
Nurix Therapeutics, Inc.
Exercise(M)Direct1.5K shares at avg. $1.86$3K - Sep 1, 2026NRIX
Nurix Therapeutics, Inc.
Sale(S)Direct1.5K shares at avg. $25.47$37K - Aug 5, 2026NRIX
Nurix Therapeutics, Inc.
Exercise(M)Direct4.4K shares at avg. $1.86$8K - Aug 5, 2026NRIX
Nurix Therapeutics, Inc.
Sale(S)Direct4.4K shares at avg. $25.00$109K - Aug 4, 2026NRIX
Nurix Therapeutics, Inc.
Sale(S)Direct2.6K shares at avg. $24.64$64K - Aug 4, 2026NRIX
Nurix Therapeutics, Inc.
Sale(S)Direct1.5K shares at avg. $23.87$36K - Jul 30, 2026NRIX
Nurix Therapeutics, Inc.
Sale(S)Direct3.8K shares at avg. $23.38$90K - Jul 30, 2026NRIX
Nurix Therapeutics, Inc.
Exercise(M)Direct3.6K shares- - Jul 30, 2026NRIX
Nurix Therapeutics, Inc.
Exercise(M)Direct2.9K shares- - Jul 30, 2026NRIX
Nurix Therapeutics, Inc.
Exercise(M)Direct3.8K shares- - Jun 25, 2026NRIX
Nurix Therapeutics, Inc.
Sale(S)Direct5.4K shares at avg. $20.00$108K - Apr 30, 2026NRIX
Nurix Therapeutics, Inc.
Exercise(M)Direct2.9K shares- - Apr 30, 2026NRIX
Nurix Therapeutics, Inc.
Sale(S)Direct3.2K shares at avg. $16.65$53K - Apr 30, 2026NRIX
Nurix Therapeutics, Inc.
Exercise(M)Direct2K shares- - Apr 30, 2026NRIX
Nurix Therapeutics, Inc.
Exercise(M)Direct3.8K shares- - Feb 10, 2026NRIX
Nurix Therapeutics, Inc.
Award(A)DirectEmployee Stock Option (right to buy)
93.8K shares- - Feb 10, 2026NRIX
Nurix Therapeutics, Inc.
Award(A)DirectRestricted Stock Units
42.9K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Nov 2, 2026 | NRIX Nurix Therapeutics, Inc. | Sale(S) | 1,452 | $26.80 | $38,914 | Direct |
| Nov 2, 2026 | NRIX Nurix Therapeutics, Inc. | Exercise(M) | 1,452 | $1.86 | $2,701 | Direct |
| Oct 30, 2026 | NRIX Nurix Therapeutics, Inc. | Exercise(M) | 3,573 | - | $0 | Direct |
| Oct 30, 2026 | NRIX Nurix Therapeutics, Inc. | Sale(S) | 3,957 | $26.28 | $103,986 | Direct |
| Oct 30, 2026 | NRIX Nurix Therapeutics, Inc. | Exercise(M) | 3,750 | - | $0 | Direct |
| Oct 30, 2026 | NRIX Nurix Therapeutics, Inc. | Exercise(M) | 2,859 | - | $0 | Direct |
| Oct 15, 2026 | NRIX Nurix Therapeutics, Inc. | Sale(S) | 1,452 | $25.00 | $36,300 | Direct |
| Oct 15, 2026 | NRIX Nurix Therapeutics, Inc. | Exercise(M) | 1,452 | $1.86 | $2,701 | Direct |
| Sep 1, 2026 | NRIX Nurix Therapeutics, Inc. | Exercise(M) | 1,452 | $1.86 | $2,701 | Direct |
| Sep 1, 2026 | NRIX Nurix Therapeutics, Inc. | Sale(S) | 1,452 | $25.47 | $36,982 | Direct |
| Aug 5, 2026 | NRIX Nurix Therapeutics, Inc. | Exercise(M) | 4,356 | $1.86 | $8,102 | Direct |
| Aug 5, 2026 | NRIX Nurix Therapeutics, Inc. | Sale(S) | 4,356 | $25.00 | $108,900 | Direct |
| Aug 4, 2026 | NRIX Nurix Therapeutics, Inc. | Sale(S) | 2,611 | $24.64 | $64,339 | Direct |
| Aug 4, 2026 | NRIX Nurix Therapeutics, Inc. | Sale(S) | 1,500 | $23.87 | $35,803 | Direct |
| Jul 30, 2026 | NRIX Nurix Therapeutics, Inc. | Sale(S) | 3,847 | $23.38 | $89,954 | Direct |
| Jul 30, 2026 | NRIX Nurix Therapeutics, Inc. | Exercise(M) | 3,572 | - | $0 | Direct |
| Jul 30, 2026 | NRIX Nurix Therapeutics, Inc. | Exercise(M) | 2,858 | - | $0 | Direct |
| Jul 30, 2026 | NRIX Nurix Therapeutics, Inc. | Exercise(M) | 3,750 | - | $0 | Direct |
| Jun 25, 2026 | NRIX Nurix Therapeutics, Inc. | Sale(S) | 5,394 | $20.00 | $107,880 | Direct |
| Apr 30, 2026 | NRIX Nurix Therapeutics, Inc. | Exercise(M) | 2,858 | - | $0 | Direct |
| Apr 30, 2026 | NRIX Nurix Therapeutics, Inc. | Sale(S) | 3,214 | $16.65 | $53,498 | Direct |
| Apr 30, 2026 | NRIX Nurix Therapeutics, Inc. | Exercise(M) | 2,000 | - | $0 | Direct |
| Apr 30, 2026 | NRIX Nurix Therapeutics, Inc. | Exercise(M) | 3,750 | - | $0 | Direct |
| Feb 10, 2026 | NRIX Nurix Therapeutics, Inc. | Award(A) Employee Stock Option (right to buy) | 93,750 | - | - | Direct |
| Feb 10, 2026 | NRIX Nurix Therapeutics, Inc. | Award(A) Restricted Stock Units | 42,875 | - | - | Direct |
1-25 of 58 transactions
About Hansen Gwenn
Hansen Gwenn (SEC CIK 0001817160) files insider reports with the SEC as Chief Scientific Officer of Nurix Therapeutics, Inc. (NRIX).
Signal8 holds 18 ownership filings by Hansen Gwenn, all Form 4s, filed between Oct 30, 2024 and Nov 2, 2026. Those filings report 58 transactions, from Oct 30, 2024 to Nov 2, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Hansen Gwenn's filings is in BRISBANE, CA.
Recent filings by Hansen Gwenn
- Nov 2, 2026: Open-market sale of NRIX shares (Form 4, code S).
- Nov 2, 2026: Option exercise of NRIX shares (Form 4, code M).
- Oct 30, 2026: Option exercise of NRIX shares (Form 4, code M).
- Oct 30, 2026: Open-market sale of NRIX shares (Form 4, code S).
- Oct 30, 2026: Option exercises of NRIX shares (2 lines, Form 4, code M).
Other insiders filing for Nurix Therapeutics, Inc. (NRIX)
- van Houte Hans, Chief Financial Officer
- Ring Christine, Chief Legal Officer
- GREGORY JULIA P, Director
- Silva Paul M, Director
- Saltzman Edward C, Director
- Reinsdorf Judith A, Director